Panhellenic Cystic Fibrosis Conference 2025 “The Journey from Diagnosis to Unlimited Breath”

  • Home
  • Panhellenic Cystic Fibrosis Conference 2025 “The Journey from Diagnosis to Unlimited Breath”
Panhellenic Cystic Fibrosis Conference 2025 “The Journey from Diagnosis to Unlimited Breath” HCFA TEAM December 20, 2025

Panhellenic Cystic Fibrosis Conference 2025 “The Journey from Diagnosis to Unlimited Breath”

The annual Panhellenic Cystic Fibrosis Conference 2025 “The Journey from Diagnosis to Unlimited Breath – Holistic Care, Lung Transplantation & Empowerment”, an all-day scientific and social meeting held on Sunday 30 November 2025, at the Amalia Hotel Athens, with live broadcast via Zoom.

This year’s conference focused on the holistic care of the Cystic Fibrosis patient, covering the journey from early diagnosis to newer therapeutic approaches and lung transplantation.

The conference presented the challenges and developments that are changing the future of Cystic Fibrosis and lung transplantation. The conference aimed at interdisciplinary collaboration, meaningful exchange of experiences and strengthening the dialogue between the scientific community, patients and society. With the active participation of representatives of institutions and organisations, the necessity to continue the effort to improve the quality of life of people with Cystic Fibrosis at all levels was highlighted.

“The Panhellenic Cystic Fibrosis Conference 2025 was an essential meeting point of knowledge, experience and human stories. From diagnosis to modern treatments and lung transplantation, we highlighted the full journey of Cystic Fibrosis patients and the need for holistic, equitable and continuous care at every stage of their lives. The progress that has been made in recent years fills us with optimism, but also with a responsibility to continue to strive for inclusive solutions for all. As the Panhellenic Cystic Fibrosis Association, we consistently continue our struggle, aiming for a future where Cystic Fibrosis will not be a barrier to life, but a manageable reality with quality, dignity and Unlimited Breath.”, said the President of the Panhellenic Cystic Fibrosis Association, Spinou Anna.

The conference was free of charge and addressed to patients, caregivers, health professionals, institutions, students, educators and the general public, with the aim of promoting awareness of Cystic Fibrosis and organ donation, as well as modern diagnosis, care and treatment of the disease.

The conference was organized by the Panhellenic Cystic Fibrosis Association under the auspices of the Hellenic Transplantation Organisation, the Hellenic Lung Society, the Hellenic Paediatric Lung Society, EURORDIS – Rare Diseases Europe, CF Europe and the Greek Patients’ Association, with the support of Platinum Sponsor Vertex Pharmaceuticals and Specialty Therapeutics, PrintServe, PARI, Oxygenium, Micrel, AskPharma.

Cystic Fibrosis is the most common hereditary disease with 1 in 2,000-2,500 children born with Cystic Fibrosis, with more than 500,000 carriers in Greece – about 5% of the general population – and more than 900 patients across the country, while the only life-saving option for patients in end-stage respiratory failure continues to be lung transplantation.

Greetings & Institutional Support

On the occasion of the 42 years of the Panhellenic Cystic Fibrosis Association, the conference began with a short speech by the President of the Association, Anna Spinou, who referred to the multidimensional work and actions of the Association, which changed the “map” of the disease in Greece.

The welcoming remarks began with a speech by the Minister of Health, Adonis Georgiades, who stressed the importance of Cystic Fibrosis as a public health priority and the commitment of the State to the continuous strengthening of care and transplantation.

The Conference was honoured with the presence and greetings of representatives of national and international health institutions, scientific societies and patient organisations, highlighting the importance of cooperation to improve the quality of life of people with Cystic Fibrosis.

Greetings were given by: Mrs . President of the Onassis Foundation, Mr. Papadimitriou Antonis, President of the Hellenic Lung Society, Mr. Loukidis Stylianos, Governor of the Agia Sophia Children’s Hospital, Mr. Michas Anastasios, Ann. Administrator of the General Hospital of Thessaloniki “G. Papanikolaou”, Mrs. Konstantinidou Anatoli, Director of Nursing Service of Sismanoglio General Hospital, Mrs. Kakogianni Andriani, President of the Panhellenic Union of Pharmacists of Nursing Institutions – PEFNI & Director of the Pharmacy of Sismanoglio, Mrs. Makridaki Despina, President of the Panhellenic Association of Physiotherapists, Mr. Mr. Alexander Tsigas, CEO Cystic Fibrosis Europe, Ms. Hilde de Keyser, Head of Public Affairs of the Hellenic Patients’ Association, Mr. Anastasios Samoilidis, Former Director of the Cystic Fibrosis Department, Aghia Sophia Children’s Hospital, Mr. Stavros Duntounakis.

Main Points & Themes

The scientific part of the conference included round tables with presentations by more than 30 renowned scientists, health professionals, representatives of institutions, patients and caregivers, who shared valuable knowledge, experiences and scientific data.

Section A: Early diagnosis and primary strategies in disease prevention and recognition
  • National strategies for the prevention and early diagnosis of Cystic Fibrosis
  • Neonatal screening & carrier screening: developments and applications of diagnostic tools
  • The role of the gynaecologist and the importance of informing young couples before conception
  • From diagnosis to care: guidance and support for young parents
  • Importance of early intervention to improve the long-term outcome of the disease
  • Diagnosis of cystic fibrosis in adulthood: The importance of awareness and education of pulmonologists for early recognition of the disease
  • National Registry of Cystic Fibrosis Patients and interface with the European Cystic Fibrosis Patient Registry (ECFSPR) as a tool for registration, monitoring and national care planning
  • The role of EDIKA in the development and exploitation of the Registry

Section B: Holistic care for children and adults, including new treatments and personalised support

  • Cystic fibrosis in children and adults: peculiarities, challenges and complications (respiratory, gastrointestinal, nasal polyps, CFRD, etc.)
  • Modern standards of care in Greece and Europe – experiences from the Centres & Cystic Fibrosis Clinics
  • Treatments, drugs and newer innovative approaches (CFTR modulators, gene therapy, etc.)
  • Personalised medicine and future perspectives in the care of patients with Cystic Fibrosis
  • Research developments and participation of Greece in European networks of clinical studies
  • The importance of nutrition in the management of Cystic Fibrosis – modern guidelines and practices
  • Nursing care and support for patients with Cystic Fibrosis – the role of the specialist nurse in multidisciplinary teams
  • The contribution of secretarial support to the operation of Cystic Fibrosis Centres – communication, organisation and liaison with patients
Section C: Lung transplantation as a final therapeutic option and the National Lung Transplant Programme
  • Lung transplantation as a final treatment option for patients with Cystic Fibrosis
  • The National Lung Transplant Programme in Greece – progress, challenges and prospects
  • Requirements, procedure and criteria for selection of patients for transplantation & long-term post-transplant care
  • Psychological dimension of transplantation; patient support before and after transplantation
  • Testimonies of transplant patients and lung transplant candidates, who participated in psychological empowerment activities of the Panhellenic Cystic Fibrosis Association
Section D: Mental health & empowerment, with a particular focus on supporting patients and carers
  • Psychiatric assessment and monitoring of patients with Cystic Fibrosis and transplant patients
  • Mental resilience, self-management and quality of life in patients with Cystic Fibrosis
  • Cystic Fibrosis hotline: a vibrant channel of communication with the community
  • Group online cognitive behavioral psychotherapy program – an innovative model of psychological support and empowerment for patients and caregivers
  • Start of a three-year randomized clinical trial for the group cognitive behavioral psychotherapy program
  • Life with Cystic Fibrosis: stories of strength from patients & caregivers who participated in the Association’s psychological empowerment activities
Section E: Educational campaign “Secret Mission: K.I.”, with actions in schools and presentation of new educational material for 3rd – 6th grade students
  • Presentation of the 2nd edition of the children’s book “Secret Mission: K.I. 2” – objectives and content
  • The power of information: how knowledge is changing social attitudes towards Cystic Fibrosis
  • The value of the Cystic Fibrosis Education Campaign for students, teachers, society: promoting acceptance and empathy in schools
  • Educational material and methods of reaching students and schools
  • Wider dissemination activities to schools, libraries and the public

During the conference, patients and caregivers shared their experiences of living with CF and lung transplantation.

Cystic Fibrosis Education Campaign

The second edition of the children’s book “Secret Mission: K.I. 2” was distributed free of charge to all attendees, marking the start of the new nationwide educational campaign “Secret Mission: K.I.”. An initiative of the Panhellenic Cystic Fibrosis Association in collaboration with the author-illustrator Liana Noezaki.

An original educational program addressed to students of 2nd, 3rd, 4th, 4th, 5th and 6th grade and aims, through the information about Cystic Fibrosis, transplantation and organ donation, to inspire every child to discover the Hidden Abilities that are hidden within him/her when faced with any visible or invisible difficulty that life brings. The innovative campaign was designed by a large multidisciplinary team under the pedagogical supervision of Dr. Zoe Crocus, Dr. Special Pedagogy. More on the campaign website: https://secretmission.cysticfibrosis.gr/

Conference Speakers

The conference was attended by more than 40 distinguished speakers from Greece and abroad, representing the scientific community, the State, international organizations and the patient community.

The sections of the conference were moderated by President Spinou Anna, Vice President Giannaki Konstantina, and the Secretary General of the Panhellenic Cystic Fibrosis Association Plala George.

Speakers of the Conference were: Adonis Georgiades, Minister of Health, Karpodini Theano, Director of EOPYY, Kani Hara, Pharmacist, Head of the EOPYY Pharmacy Department, Kakoyannis Andriani, Director of Nursing, Sismanoglio General Hospital, Papatheodoridis Georgios, President of the National Transplantation Organization, Professor of Medicine, Director of the University Gastroenterology Clinic and Director of the Liver Transplantation Unit of the “LIKO” General Hospital, Boletis Ioannis, President of Onassis Cardiosurgery Center, Professor of Pathology-Nephrology, School of Medicine of the University of Athens, Papadimitriou Antonis, President of Onassis Foundation, Loukidis Stylianos, President of the Hellenic Lung Society, Michas Anastasios, Director of “Aghia Sophia” Children’s Hospital, Konstantinidou Anatoli, Anatoli. Administrator of the General Hospital of Thessaloniki “G. Papanikolaou”, Kakogianni Andriani, Director of Nursing Services of the General Hospital of G.G.A. Sismanoglio, Makridaki Despina, President of the Panhellenic Union of Pharmacists of Nursing Institutions – PEFNI & Director of the Pharmacy of Sismanoglio, Lymperidis Petros, President of the Panhellenic Association of Physiotherapists, Tsigas Alexandros, Dietitian, MSc, PhDc Clinical Nutrition, Scientific Associate of Harokopio University, Treasurer of the Panhellenic Association of Dietitians – Nutritionists (P.S.D.D.) & Member of the Clinical Nutrition Working Group, Hilde de Keyser, CEO Cystic Fibrosis Europe, Samouilidis Anastasios, Head of Public Affairs of the Hellenic Patients’ Association, Dountounakis Stavros, Former Director of the Cystic Fibrosis Department, Aghia Sophia Children’s Hospital, Spinou Anna, President of the Panhellenic Cystic Fibrosis Association, Member of the Working Group of the National Cystic Fibrosis Registry, Member of the Board of Directors. European Organization Eurordis- Rare Diseases Europe, Patient Representative ePAG representative ERN Lung, European Patients’ Academy (EUPATI) fellow, Retired Administrative Employee of Attikon General Hospital, Patient with Cystic Fibrosis, Tsanakas Ioannis, Coordinator of the Working Group of the National Cystic Fibrosis Registry, Scientific, Head of the Working Group of the Ministry of Health of the Hospital at Home Programme, Professor Emeritus of Paediatrics – Paediatric Pulmonology A.P.TH., Kanaka-Gantenbein Christina, President of the Institute of Child Health, Professor of Pediatrics-Pediatric Endocrinology, Director of the First Pediatric Clinic and Research Laboratory of the National Research Laboratory of the National Institute of Pediatrics, Endo-ERN Aghia Sophia Children’s Hospital representative, Member of the National Committee for Rare Diseases, Scientific Officer of the Expertise Centre for Rare Endocrine Diseases in Children, Makrytanasis Pericles, Associate Professor of Pediatric Endocrinology, Member of the National Committee for Rare Diseases, Scientific Officer of the Centre of Expertise for Rare Endocrine Diseases in Children. Professor of Medical Genetics, Faculty of Medicine, H.C.P.A, Director of the Medical Genetics Laboratory, Aghia Sophia Children’s Hospital, Angeliki Balasopoulou, Biologist, Laboratory Geneticist, Laboratory of Haemoglobinopathies and Cystic Fibrosis, Unit of Mediterranean Anaemia, Theodora Marianna, Obstetrician- Gynaecologist, Assistant Professor of Obstetrics and Gynaecology at the University of Athens – Alexandra Hospital, Member of the Board of the Hellenic Society of Obstetric and Gynaecological Emergencies (HESGE), Petrochilou Argyri, Paediatrician – Paediatric Pulmonologist, Attending Nurse A’, Cystic Fibrosis Department, Aghia Sophia Children’s Hospital, Georgakopoulou Vasiliki, Pulmonologist – Tuberculologist, Attending Nurse B’, Infectious Diseases Unit, Department of Pathological Physiology, University of Athens, Greece, Laiko Hospital, Head of the Respiratory System Infections Working Group of the Hellenic Respiratory Society (HPS), Mitrou Panagiota, Head of the Department of Therapeutic Protocols and Registries of the Ministry of Health, Lutz Nährlich, Professor of General Pediatrics, Pediatric Allergology, Pediatric Pulmonology & Cystic Fibrosis, Director, University Hospital Gießen and Marburg, Germany, Member of the Executive Committee of the European Cystic Fibrosis Registry ECFSPR, Zographopoulos Dimitris, Data Protection Officer (DPO), Ministry of Health, Davis Maria, Head of Production Operations, EDIKA, Loukou Ioanna, MD, MSc, PhD, Pediatrician-Pediatric Pulmonologist, Coordinating Director of the Cystic Fibrosis Department, Aghia Sophia Children’s Hospital, Athens, Diamantea Filia, Pulmonologist, Director of the NHS, Scientific Head of the Adult Cystic Fibrosis Unit, Sismanoglio General Hospital, Hatziagorou Elpida, Professor of Pediatrics and Pediatric Pediatric Pulmonology A.P.TH, Head of the Cystic Fibrosis Unit of the General Hospital “Hippokratio”, Manika Aikaterini, Associate Professor of Pulmonology and Pneumology of the Aristotle University of Thessaloniki, Center of Cystic Fibrosis for Adults, Pulmonology Clinic of the Aristotle University of Thessaloniki, General Hospital “G. Papanikolaou”, Fotoulaki Maria, Professor of Paediatric Gastroenterology at the Aristotle University of Thessaloniki, Director of Paediatric Gastroenterology, Hepatology and Nutrition, General Hospital “G. Papageorgiou”, Emmanuel Paraskakis, Senior Lecturer, G.G. Papageorgiou, G.G. Papageorgiou. Professor of Pediatrics, University of Crete, Head of the Cystic Fibrosis Clinic for Children, University General Hospital of Heraklion, Crete (PEPAGNI), Perlepe Faye, Pulmonologist, Doctor of the University of Thessaly, Department of Medicine, Pulmonology Clinic of the University of Thessaly, Head of the Cystic Fibrosis Clinic for Adults, University General Hospital of Larissa, Lyberi Maria, Dr., Scientific Editor of Human Gene Therapy, former Vice President of Research – Spirovant Bio, former Professor – University of Pennsylvania, Hadjipanagiotou Ioanna, Nurse of the Adult Cystic Fibrosis Unit, Sismanoglio, Tsakona Anna, Secretary of the Adult Cystic Fibrosis Unit, Papanikolaou General Hospital, Tsagaris Hercules, Professor of Pulmonology – Intensive Care, Director of the Intensive Care Clinic of Attikon General Hospital, Scientific Manager of the Lung Transplantation Center of Onassis Cardiac Surgery Center, Frantzeskaki Francesca, Pulmonologist – Intensivist, Attikon Intensive Care Clinic, Attikon General Hospital, Theodoropoulos Fotis, Attending Lung Specialist, Onassis Cardiosurgery Center, Guttmacher Vassilis, Dr, Clinical Psychologist, Joka Anna, Central Coordinator, Hellenic Transplantation Organization (HTO), Katsini Irini, Senior Consultant in Psychiatry, Asclepion Voula General Hospital, former Vice President of the Panhellenic Cystic Fibrosis Association, Cystic Fibrosis Patient, Rakitzi Stavroula, Dr., Dipl.-Psychologist Clinical psychologist with competence in Cognitive Behavioral Psychotherapy, Volunteer – Head of the group psychotherapy program of the Panhellenic Cystic Fibrosis Association, Pavlidi Irini, Psychologist – Mental Health Counselor, Volunteer – Head of the Cystic Fibrosis Support Line, Liana Nemezaki, Author and illustrator of children’s books, Co-founder of “Yellow Patini” publications, Kumaki Kalliopi, Primary Education Teacher, Cystic Fibrosis patient.

Their stories were shared by patients Tiglianidou Melina, Paliou Maria, Diliou Dimitra(transplant recipient), Antonopoulos Dimitris† (psychotherapeutic message in memory of Rakitzis Stavroula), Gini Despina (candidate for lung transplantation) and patient caregivers Bozini Irini and Giannaki Konstantina.